Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.24%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.58%
#5 Humanity Humanity +28.27%
#6 Codatta Codatta +18.76%
#7 Walrus Walrus +17.42%
#8 Enso Enso +17.35%
#9 The Black Bull The Black Bull +14.68%
#10 Collector Crypt Collector Crypt +14.46%
Coin of the day
EXOD EXOD
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
शेयरों में रैंक #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
शेयर मूल्य
$0.117
अंतिम समन्वयन: 2025-04-04
मार्केट कैप
$2.45M
बदलाव (1 दिन)
-13.59%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Carmell Therapeutics Corporation (CTCX)

श्रेणी

Healthcare
Carmell Therapeutics Corporation (CTCX) के लिए P/B अनुपात
August 2026 को P/B अनुपात TTM: -0.06
Carmell Therapeutics Corporation की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) -0.06 है। 2023 के अंत में, कंपनी का P/B अनुपात 95.93 था।
Carmell Therapeutics Corporation के लिए 2021 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
2026 (TTM) -0.06 -99.85%
2024 -37.13 -138.70%
2023 95.93 -161.62%
2022 -155.68 -19.29%
2021 -192.90 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -11,404.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -11,225.31%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -6,269.70%
BE